These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8073823)

  • 61. Widespread cutaneous carcinomas associated with human papillomaviruses 5, 14 and 20 after introduction of methotrexate in two long-term PUVA-treated patients.
    Zumtobel U; Schwarze HP; Favre M; Taïeb A; Delaunay M
    Dermatology; 2001; 202(2):127-30. PubMed ID: 11306834
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differential effects of treatment with UV-light (365 nm) and 8-methoxypsoralen on chromosomes of healthy persons and psoriatic patients.
    Löber G; Kittler L; Beensen V; Schaarschmidt H; Knopf B
    Biomed Biochim Acta; 1986; 45(3):343-51. PubMed ID: 3707553
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
    Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Multiple keratoses and squamous carcinoma after PUVA treatment of vitiligo.
    Buckley DA; Rogers S
    Clin Exp Dermatol; 1996 Jan; 21(1):43-5. PubMed ID: 8689768
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Determination of 8-methoxypsoralen kinetics: a relevant factor in the treatment of psoriasis by psoralen plus ultraviolet A therapy.
    Bonnot D; Béani JC; Boitard M; Reymond JL; Bériel H; Amblard P
    Photodermatol Photoimmunol Photomed; 1994 Feb; 10(1):33-7. PubMed ID: 8180098
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Influence of systemic photochemotherapy on regulatory T cells and selected cytokine production in psoriatic patients: a pilot study.
    Rotsztejn H; Zalewska A; Trznadel-Budźko E; Lewkowicz P; Banasik M; Tchórzewski H; Głowacka E
    Med Sci Monit; 2005 Dec; 11(12):CR594-8. PubMed ID: 16319792
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Peripheral blood T-lymphocyte subsets in the follow-up of psoriasis patients under PUVA therapy.
    Caranzan FR; Bene MC; Faure GC
    Photodermatol; 1987 Jun; 4(3):135-40. PubMed ID: 3500463
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Razoxane in the treatment of psoriatic patients resistant to or intolerant of PUVA, methotrexate and etretinate.
    Mom A; Aresca S; Fuente G; Pecorini V; Pellerano G; Perez V
    Acta Derm Venereol; 1982; 62(4):357-8. PubMed ID: 6183878
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Early dermato-pathological signs during bath-PUVA therapy.
    Piérard-Franchimont C; Nickels-Read D; Ben Mosbah T; Arrese Estrada J; Piérard GE
    J Pathol; 1990 Jul; 161(3):227-31. PubMed ID: 1975271
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Growth of finger nails in psoriasis patients undergoing PUVA therapy].
    Landherr G; Braun-Falco O; Hofmann C; Plewig G; Galosi A
    Hautarzt; 1982 Apr; 33(4):210-3. PubMed ID: 7096084
    [TBL] [Abstract][Full Text] [Related]  

  • 71. PUVA therapy in Thai psoriatic patients.
    Rajatanavin N; Timpatanapong P; Polnikorn N
    J Med Assoc Thai; 1987 Apr; 70 Suppl 3():26-30. PubMed ID: 3625076
    [No Abstract]   [Full Text] [Related]  

  • 72. Differential effects of PUVA treatment on chromosomes of healthy persons and psoriatic patients. In vitro and in vivo results.
    Löber G; Bach H; Beensen V; Kittler L; Schaarschmidt H; Knopf B
    Dermatol Monatsschr; 1985; 171(12):777-87. PubMed ID: 4092788
    [No Abstract]   [Full Text] [Related]  

  • 73. Rheological properties of the blood in psoriasis patients during PUVA-therapy.
    Mordovtsev VN; Tepljuk NP; Firsov NN; Kirsanova MM
    Dermatol Monatsschr; 1989; 175(7):437-42. PubMed ID: 2792487
    [TBL] [Abstract][Full Text] [Related]  

  • 74. PUVA treatment in Sweden.
    Lindelöf B; Sigurgeirsson B
    Acta Derm Venereol Suppl (Stockh); 1991; 169():3-6. PubMed ID: 1814139
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Nevus spilus-like hyperpigmentation in psoriatic lesions during PUVA therapy.
    Helland S; Bang G
    Acta Derm Venereol; 1980; 60(1):81-3. PubMed ID: 6153845
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Epidermal dystrophy and actinic keratoses in psoriasis patients following oral psoralen photochemotherapy (PUVA). Follow-up study.
    Abel EA; Cox AJ; Farber EM
    J Am Acad Dermatol; 1982 Sep; 7(3):333-40. PubMed ID: 7130492
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Expression of p53 protein before and after PUVA treatment in psoriasis.
    Hannuksela-Svahn A; Pääkkö P; Autio P; Reunala T; Karvonen J; Vähäkangas K
    Acta Derm Venereol; 1999 May; 79(3):195-9. PubMed ID: 10384915
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Appearance of disseminated hyperpigmented lesions during PUVA therapy].
    Szekeres E; Török L; Szücs M
    Hautarzt; 1981 Jan; 32(1):33-5. PubMed ID: 7228659
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Skin cancers or premalignant lesions occur in half of high-dose PUVA patients.
    Lever LR; Farr PM
    Br J Dermatol; 1994 Aug; 131(2):215-9. PubMed ID: 7917985
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antiangiogenic effect of methotrexate and PUVA on psoriasis.
    Shaker OG; Khairallah M; Rasheed HM; Abdel-Halim MR; Abuzeid OM; El Tawdi AM; El Hadidi HH; Ashmaui A
    Cell Biochem Biophys; 2013 Nov; 67(2):735-42. PubMed ID: 23504632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.